Literature DB >> 20835718

Multimedia article. Sphincterotome stricturoplasty for long ampullary stenoses and benign biliary strictures (with video).

Shou-Jiang Tang1, Sundeep Singh, Shailender Singh.   

Abstract

BACKGROUND: Long ampullary stenoses and fibrotic distal biliary strictures are not infrequently encountered during endoscopic retrograde cholangiopancreatography (ERCP). Instead of balloon dilation and stenting, we propose that these strictures can be managed with sphincterotome stricturoplasty (SS) during the initial ERCP.
OBJECTIVE: To report our clinical experience with SS for benign distal biliary strictures.
DESIGN: Review on prospectively collected data. PATIENTS: All (consecutive) patients who underwent ERCP and SS performed by the authors in a 12-month period. Long ampullary stenosis and/or distal biliary stricture is defined as significant narrowing of CBD from the level of duodenal wall into the common bile duct (CBD) after initial sphincterotomy. The upstream CBD is dilated. Despite adequate ES, contrast drainage is poor due to the downstream stricture. SS was performed using the same sphincterotome in slightly bowed position under endoscopic and fluoroscopic guidance. The cutting wire was placed parallel to the superior border within the stricture and incising the stenosis. In cases of relatively long strictures, during initial SS the majority of the cutting wire was inside the biliary opening. This differs from ES, where about one-third to one-half of the length of cutting wire is outside the ampulla. MEASUREMENTS: Clinical data, hospital course, procedure-related complication rates, and outcomes were prospectively collected in a database.
RESULTS: During the study period, 308 ERCPs were performed. Benign and short (≤15 mm in length) distal biliary strictures were observed in 25 patients. Mean ± SD stricture length was 7.4 ± 3.0 mm. The presumed etiologies for these strictures were choledocholithiasis (n = 22) and postsphincterotomy stenosis (n = 3). There was no perforation, post-ERCP pancreatitis, postsphincterotomy bleeding, or cholangitis. To date, none of these patients who had SS have needed follow-up ERCP. LIMITATIONS: Single-operator experience, limited follow-up period.
CONCLUSIONS: Compared with balloon stricturoplasty ± biliary stenting, SS is a simple and cost-effective alternative option in managing long ampullary stenosis and/or distal fibrotic biliary stricture during the initial ERCP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20835718     DOI: 10.1007/s00464-010-1340-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  8 in total

Review 1.  Ampulla of Vater. Anatomic, embryologic, and surgical aspects.

Authors:  C Avisse; J B Flament; J F Delattre
Journal:  Surg Clin North Am       Date:  2000-02       Impact factor: 2.741

2.  Sphincterotomy-associated biliary strictures: features and endoscopic management.

Authors:  M J Bourke; A B Elfant; R Alhalel; D Scheider; P Kortan; G B Haber
Journal:  Gastrointest Endosc       Date:  2000-10       Impact factor: 9.427

3.  Endoscopic treatment of sphincterotomy-associated distal common bile duct strictures by using sequential insertion of multiple plastic stents.

Authors:  József Pozsár; Péter Sahin; Ferenc László; Lajos Topa
Journal:  Gastrointest Endosc       Date:  2005-07       Impact factor: 9.427

4.  [Endoscopic sphincterotomy of the papilla of vater and extraction of stones from the choledochal duct (author's transl)].

Authors:  M Classen; L Demling
Journal:  Dtsch Med Wochenschr       Date:  1974-03-15       Impact factor: 0.628

Review 5.  Technology assessment status evaluation: balloon dilation of gastrointestinal tract strictures. American Society for Gastrointestinal Endoscopy.

Authors:  M B Kimmey; F H Al-Kawas; R M Gannan; Z A Saeed; D L Carr-Locke; S A Edmundowicz; P A Jamidar; T N Stein
Journal:  Gastrointest Endosc       Date:  1995-12       Impact factor: 9.427

6.  Safety and utility of ERCP during pregnancy.

Authors:  Shou-Jiang Tang; Marlyn J Mayo; Edmundo Rodriguez-Frias; Luis Armstrong; Linda Tang; Jayaprakash Sreenarasimhaiah; Luis F Lara; Don C Rockey
Journal:  Gastrointest Endosc       Date:  2009-01-10       Impact factor: 9.427

7.  Endoscopic sphincterotomy plus large-balloon dilation versus endoscopic sphincterotomy for removal of bile-duct stones.

Authors:  Jeung Ho Heo; Dae Hwan Kang; Hyo Jin Jung; Dae Sik Kwon; Jin Kwang An; Bo Suk Kim; Kyung Duk Suh; Sang Yong Lee; Joo Ho Lee; Gwang Ha Kim; Tae Oh Kim; Jeong Heo; Geun Am Song; Mong Cho
Journal:  Gastrointest Endosc       Date:  2007-10       Impact factor: 9.427

8.  Iatrogenic ampullary stenosis: history, endoscopic management, and outcome in a series of 49 patients.

Authors:  Mariëlle C Veldkamp; Erik A J Rauws; Marcel G Dijkgraaf; Paul Fockens; Marco J Bruno
Journal:  Gastrointest Endosc       Date:  2007-07-20       Impact factor: 9.427

  8 in total
  4 in total

1.  Complications of endoscopic retrograde cholangiopancreatography: how to avoid and manage them.

Authors:  Nicholas M Szary; Firas H Al-Kawas
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-08

Review 2.  Endoscopic retrograde cholangiopancreatography versus intraoperative cholangiography for diagnosis of common bile duct stones.

Authors:  Kurinchi Selvan Gurusamy; Vanja Giljaca; Yemisi Takwoingi; David Higgie; Goran Poropat; Davor Štimac; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2015-02-26

Review 3.  Endoscopic ultrasound versus magnetic resonance cholangiopancreatography for common bile duct stones.

Authors:  Vanja Giljaca; Kurinchi Selvan Gurusamy; Yemisi Takwoingi; David Higgie; Goran Poropat; Davor Štimac; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2015-02-26

Review 4.  Ultrasound versus liver function tests for diagnosis of common bile duct stones.

Authors:  Kurinchi Selvan Gurusamy; Vanja Giljaca; Yemisi Takwoingi; David Higgie; Goran Poropat; Davor Štimac; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2015-02-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.